BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2164614)

  • 21. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
    Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
    Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estrogen receptor status of breast cancer patients].
    Winzer KJ; Saul G; Sinn B; Kranz D; Wolff H; Rose H
    Zentralbl Chir; 1986; 111(15):915-20. PubMed ID: 3020841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of estrogen receptor immunocytochemical assay (ER-ICA) and estrogen receptor enzyme immunoassay (ER-EIA) for the determination of estrogen receptor status in breast carcinoma. A comparative study on frozen sections, cytological smears and tissue homogenates.
    Szadowska A; Lasota J; Kubiak R; Graczyk G
    Patol Pol; 1991; 42(1):17-23. PubMed ID: 1845477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
    Thorpe SM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of imprint cytology in cytochemical detection of steroid hormone receptors in breast cancer.
    Masood S; Johnson H
    Am J Clin Pathol; 1987 Jan; 87(1):30-6. PubMed ID: 2432772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between histopathologic features and estrogen receptor status in primary breast cancer.
    Mantouvalos H; Makrygiannakis A; Metallinos C; Yianniou A; Gouskos A
    Int J Gynaecol Obstet; 1984 Jun; 22(3):177-9. PubMed ID: 6148273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies of estrogen receptor determinations by enzyme immuno-assay using the monoclonal antibody, dextran-coated charcoal, and sucrose density gradient methods].
    Tominaga T; Yoshida Y; Kitamura M; Kosaki G
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1782-6. PubMed ID: 2412495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of ER-D5 immunocytochemical determination in routine tissue sections of human breast cancer.
    Giani C; Campani D; De Negri F; Perpoli F; Capotorti E; Squartini F; Pinchera A
    Int J Biol Markers; 1989; 4(1):1-7. PubMed ID: 2545793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunocytochemical assay of estrogen receptors in puncture products of breast carcinomas].
    Faverly D; Querton G; Degeyter M; Lenglet G; Devleeschouwer N; Leclercq G
    Bull Cancer; 1990; 77(7):667-74. PubMed ID: 2207355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.
    von Kleist S; Berling J; Koltzenburg J; Gropp H
    J Cancer Res Clin Oncol; 1988; 114(6):623-7. PubMed ID: 2462564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of four immunochemical methods for the measurement of oestrogen receptor levels in breast cancer.
    Ryde CM; Smith D; King N; Trott PA; MacLennan K; McKinna JA; Minasian H; Dowsett M
    Cytopathology; 1992; 3(3):155-60. PubMed ID: 1511120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme immunoassay and Scatchard plot estimation of estrogen receptor in gynecological tumors.
    Spona J; Gitsch E; Kubista E; Salzer H; Köhler B
    Cancer Res; 1986 Aug; 46(8 Suppl):4310s-4312s. PubMed ID: 2425949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of cytologic smears and frozen-tissue sections in the determination of sex steroid receptor status of breast carcinomas.
    Johnson H; Mir R; Richer S; Wise L
    Surgery; 1987 Oct; 102(4):628-34. PubMed ID: 3310298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and progesterone receptors revealed by an immunoperoxidase method.
    Pelusi G; D'Errico A; Cavallina R; Cunsolo A; Jasonni VM; Eusebi V
    Eur J Gynaecol Oncol; 1983; 4(2):94-6. PubMed ID: 6191985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
    Masood S
    Arch Pathol Lab Med; 1989 Jan; 113(1):26-30. PubMed ID: 2462858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oestrogen receptors in mucinous carcinoma of the breast: an immunohistological study using paraffin wax sections.
    Shousha S; Coady AT; Stamp T; James KR; Alaghband-Zadeh J
    J Clin Pathol; 1989 Sep; 42(9):902-5. PubMed ID: 2551929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor analyses in breast cancer: comparison of monoclonal immunohistochemical and biochemical methods.
    Søndergaard G; Pedersen KO; Paulsen SM
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1425-9. PubMed ID: 2480241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of an estrogen receptor-related phosphoprotein with histopathological features in breast cancer.
    Tomasino RM; Daniele E; Nuara R; Morello V; Salvato M; Florena AM
    Int J Biol Markers; 1989; 4(2):95-102. PubMed ID: 2549126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
    Pertschuk LP; Feldman JG; Kim YD; Braithwaite L; Schneider F; Braverman AS; Axiotis C
    Cancer; 1996 Jun; 77(12):2514-9. PubMed ID: 8640700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.